• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

9th LuCE Report on Lung Cancer: Launch Event

We are pleased to present the 9th Report, titled `Empowering voices: Knowledge and decision-making among people impacted by lung cancer […]

‘Get Educated!’ 2024 Public Awareness Campaign – Press Release

Monday, November 11, 2024 Lung Cancer Europe (LuCE) announces the launch of its 2024 awareness campaign, “Get Educated.” This is […]

Madrid hosts LuCE Members Meeting

The Members Meeting of Lung Cancer Europe (LuCE) starts this Friday, October 4th, 2024 in Madrid. Each year LuCE provides […]

LuCE presents country reports based on 2023 research on financial toxicity

We are pleased to announce the launch of nine Lung Cancer Europe (LuCE) country reports based on the data from […]

LuCE seeks to fill key roles

Join our team at Lung Cancer Europe (LuCE) and become part of a dedicated group of individuals who are driven […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]